Clinical characteristics of tumors derived from colorectal cancer patients who harbor the Tumor Necrosis Factor α-1031T/T and NOD2 3020insC polymorphism

Cancer Epidemiology

Volumn 33, Issue 2, 2009, Pages 161-163

  Kładny, Józef ^a   Suchy, Janina ^a   Kłujszo Grabowska, Ewa ^a   Kacperski, Tomasz ^a   Scott, Rodney J ^b   Kurzawski, Grzegorz ^a   Lubiński, Jan ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Clinical characteristics; Colorectal cancer; NOD2; TNF

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; DNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL FEATURE; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; POLYP; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC; PROGNOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68149132850     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2009.06.004     Document Type: Article

References (13)

1. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 6917 (2002) 860-867
2. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2 (2003) 1-5
3. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 6837 (2001) 603-606
4. Hampe J., Cuthbert A., Croucher P.J., Mirza M.M., Mascheretti S., Fisher S., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 9272 (2001) 1925-1928
5. Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., and Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276 7 (2001) 4812-4818
6. Inohara N., Ogura Y., Chen F.F., Muto A., and Nunez G. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 276 4 (2001) 2551-2554
7. Gutierrez O., Pipaon C., Inohara N., Fontalba A., Ogura Y., Prosper F., et al. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 277 44 (2002) 41701-41705
8. Kurzawski G., Suchy J., Kladny J., Grabowska E., Mierzejewski M., Jakubowska A., et al. The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res 64 5 (2004) 1604-1606
9. Papaconstantinou I., Theodoropoulos G., Gazouli M., Panoussopoulos D., Mantzaris G.J., Felekouras E., et al. Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer 114 (2005) 433-435
10. Roberts R.L., Gearry R.B., Allington M.D., Morrin H.R., Robinson B.A., and Frizelle F.A. Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer. Cancer Res 66 (2006) 2532-2535
11. Lakatos P.L., Hitre E., Szalay F., Zinober K., Fuszek P., Lakatos L., et al. Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. BMC Cancer 7 (2007) 54
12. Alhopuro P., Ahvenainen T., Mecklin J.P., Juhola M., Jarvinen H.J., Karhu A., et al. NOD2 3020insC alone is not sufficient for colorectal cancer predisposition. Cancer Res 64 (2004) 7245-7247
13. Suchy J., Kłujszo-Grabowska E., Kładny J., Cybulski C., Wokołorczyk W., Szymańska-Pasternak J., et al. Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer 8 (2008) 112